What is the price target for THTX stock?
10 analysts have analysed THTX and the average price target is 4.09 USD. This implies a price increase of 20.63% is expected in the next year compared to the current price of 3.39.
THERATECHNOLOGIES INC (THTX) Forecast, Price Target & Analyst Ratings
NASDAQ:THTX • CA88338H7040
Current stock price
3.39 USD
0 (0%)
At close:
3.4 USD
+0.01 (+0.29%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for THERATECHNOLOGIES INC (THTX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Oct 8, 2025
- Period
- Q3 / 2025
- EPS Estimate
- -$0.01
- Revenue Estimate
- 20.214M
Price Target Details & History
Consensus Price Target and Range
Mean target
$4.09
Upside
+ 20.63%
From current price of $3.39 to mean target of $4.09, Based on 10 analyst forecasts
Low
$2.79
Median
$4.09
High
$5.52
Price Target Revisions
1 Month
0.63%
3 Months
-1.02%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for THTX. The average price target is 4.09 USD. This implies a price increase of 20.63% is expected in the next year compared to the current price of 3.39.
The average price target has been revised downward by 1.02% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.00%
THTX was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about THTX.
In the previous month the buy percentage consensus was at a similar level.
THTX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-07-03 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-10-11 | Jones Trading | Downgrade | Buy -> Hold |
| 2023-07-17 | JonesTrading | Maintains | Buy -> Buy |
| 2023-07-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2022-11-17 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-02-27 | Leede Jones Gab | Downgrade | Speculative Buy -> Hold |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Oct 8, 2025
- Period
- Q3 / 2025
- EPS Estimate
- -$0.01
- Revenue Estimate
- 20.214M
- Revenue Q2Q
- -10.56%
- EPS Q2Q
- -117.17%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
-7.92%
Revenue (3 Months)
-10.34%
EPS (1 Month)
-166.67%
EPS (3 Months)
-125.00%
Next Earnings Summary
THTX is expected to report earnings on 10/8/2025. The consensus EPS estimate for the next earnings is -0.01 USD and the consensus revenue estimate is 20.21M USD.
The next earnings revenue estimate has been revised downward by 10.34% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2025 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 80.057M 14.66% | 81.764M 2.13% | 85.866M 5.02% | 83.871M -2.32% | 95.414M 13.76% | 102.32M 7.24% | 100.4M -1.88% | 102.4M 1.99% | 104.42M 1.97% | 152.9M 46.43% | 154.63M 1.13% | |
| EBITDA YoY % growth | -27.437M -66.41% | -7.312M 73.35% | 10.935M 249.55% | 12.354M 12.98% | 27.022M 118.73% | 34.844M 28.95% | 37.514M 7.66% | 41.868M 11.61% | 44.745M 6.87% | 90.874M 103.09% | 91.962M 1.20% | |
| EBIT YoY % growth | -39.908M -58.14% | -10.627M 73.37% | 8.174M 176.92% | 5.647M -30.92% | 14.74M 161.02% | 20.878M 41.64% | 29.26M 40.15% | 34.02M 16.27% | 47.445M 39.46% | 47.952M 1.07% | 45.148M -5.85% | |
| Operating Margin | -49.85% | -13.00% | 9.52% | 6.73% | 15.45% | 20.40% | 29.14% | 33.22% | 45.44% | 31.36% | 29.20% | |
| EPS YoY % growth | -2.00 -488.24% | -0.95 52.50% | -0.18 81.05% | -0.02 88.56% | 0.14 783.35% | 0.21 48.77% | 0.27 29.35% | 0.30 11.06% | 0.36 20.13% | 3.07 750.21% | 3.44 12.07% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 -117.17% | 0.03 119.31% | 0.01 | 0.01 111.44% | 0.02 300.00% | 0.03 |
| Revenue Q2Q % growth | 20.214M -10.56% | 22.642M -9.44% | 21.695M 13.90% | 22.358M 26.11% | 23.229M 14.92% | 24.161M 6.71% |
| EBITDA Q2Q % growth | 5.169M -39.05% | 4.967M 34.97% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 478.95K -92.29% | 2.624M 185.53% | 1.462M -22.85% | 1.822M 434.31% | 2.371M 395.04% | 2.972M 13.26% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
46.80%
EPS Next 5 Year
29.71%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
5.76%
Revenue Next 5 Year
3.44%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
43.20%
EBIT Next 5 Year
28.68%
THERATECHNOLOGIES INC / THTX Forecast FAQ
Can you provide the upcoming earnings date for THERATECHNOLOGIES INC?
THERATECHNOLOGIES INC (THTX) will report earnings on 2025-10-08, before the market open.
What are the consensus estimates for THERATECHNOLOGIES INC (THTX) next earnings?
The consensus EPS estimate for the next earnings of THERATECHNOLOGIES INC (THTX) is -0.01 USD and the consensus revenue estimate is 20.21M USD.
Can you provide the expected long term growth rate for THERATECHNOLOGIES INC stock?
The expected long term growth rate for THERATECHNOLOGIES INC (THTX) is 5.76%.